VASOACTIVE INTESTINAL PEPTIDE (VIP) AND PEPTIDE HISTIDINE ISOLEUCINE (PHI) KNOCKOUT MICE  
UCLA Technology Available For Licensing

BACKGROUND:  VIP and PHI are expressed at high levels in the neurons of the suprachiasmatic nucleus, the area of the nervous system responsible for most circadian behavior, but their function in the regulation of circadian rhythms is unknown. In order to study the role of these peptides on the circadian system in vivo, a new mouse model was developed in which both VIP and PHI genes were disrupted by homologous recombination.

INNOVATION:  In a light-dark cycle, the knockout mice were indistinguishable from control mice. However, in constant darkness, the VIP/PHI-deficient mice exhibited pronounced abnormalities in their circadian system. The VIP/PHI-deficient mice also exhibited deficits in the response of their circadian system to light. Researchers conclude that VIP/PHI peptides are critically involved in both the generation of circadian oscillations as well as the normal synchronization of these rhythms to light.

POTENTIAL APPLICATIONS 

Related Papers (Selected)

Reference: UCLA Case No. 2001-173

For additional technical details and current licensing
availability, please contact the following UCLA office:

UCLA Office of Intellectual Property
11000 Kinross Avenue, Suite #200
Los Angeles, CA 90095
Tel: 310-794-0558 Fax: 310-794-0638
email: ncd@research.ucla.edu
NCD URL:   http://www.research.ucla.edu/tech/ucla01-173.htm

Lead Inventor: James Waschek

UCLA Technologies Available for Licensing
http://www.research.ucla.edu/oipa/industry

Copyright © 2008 The Regents of the University of California.

keywords: research tools mouse models drug development uclancd ucla latest inventions technology top ten 10 technologies intellectual property patents technology transfer invention business card